as on September 18, 2025 at 1:29 am IST
Day's High
5.26%
Upside
52 Week's Low
52 Week's High
80.09%
Downside
585.95%
Upside
Check Klotho Neurosciences Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$35.9M
EPS (TTM)
0Dividend Yield
0.00%
PE Ratio (TTM)
0P/B Ratio
0PEG Ratio
0Return On Equity TTM
97683700.00%
Compare market cap, revenue, PE, and other key metrics of Klotho Neurosciences Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
NA | $35.9M | NA | NA | 0.00% | |
BUY | $60.5B | 252.04% | -505.15 | -12.96% | |
NA | $39.0B | NA | NA | -3.89% | |
BUY | $100.3B | 44.17% | 27.85 | 31.86% | |
BUY | $59.6B | 1.78% | 14.1 | 31.37% |
The Klotho Neurosciences Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Klotho Neurosciences Inc investment value today
Current value as on today
₹65,889
Returns
Returns from Klotho Neurosciences Inc Stock
Dollar Returns*
₹4,598 (+4.6%)
Search interest for Klotho Neurosciences Inc Stock has decreased by -17% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 68.9% return, outperforming this stock by 102.6%
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.5% return, outperforming this stock by 210.5%
Price Dip
In the last 1 month, KLTO stock has moved down by -24.9%
Organisation | Klotho Neurosciences Inc |
Headquarters | 13576 Walnut Street, Omaha, NE, United States, 68144 |
CEO | Dr. Joseph Sinkule Pharm.D. |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Dr. Joseph Sinkule Pharm.D. | Founder, CEO, Chairman of the Board & Secretary |
Mr. Jeffrey LeBlanc | Chief Financial Officer |
Dr. Shalom Z. Hirschman M.D. | Medical Advisor & Director |
Mr. Peter J. Moriarty | Chief Business Officer |
Klotho Neurosciences Inc share price today is $0.57 as on at the close of the market. Klotho Neurosciences Inc share today touched a day high of $0.6 and a low of $0.57.
Klotho Neurosciences Inc share touched a 52 week high of $3.91 on and a 52 week low of $0.11 on . Klotho Neurosciences Inc stock price today i.e. is closed at $0.57,which is 85.42% down from its 52 week high and 402.20% up from its 52 week low.
Klotho Neurosciences Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Klotho Neurosciences Inc (KLTO) shares with as little as ₹87.816 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹878.16 in Klotho Neurosciences Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Klotho Neurosciences Inc share’s latest price of $0.57 as on September 18, 2025 at 1:29 am IST, you will get 17.5439 shares of Klotho Neurosciences Inc. Learn more about
fractional shares .